SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mariana Rieck, Artur F Schumacher-Schuh, Sidia M Callegari-Jacques, Vivian Altmann, Márcio Schneider Medeiros, Carlos RM Rieder, Mara H Hutz, Is there a role forADORA2Apolymorphisms in levodopa-induced dyskinesia in Parkinson's disease patients?, Pharmacogenomics, 2015, 16, 6, 573

    CrossRef

  2. 2
    Antoni Cortés, Eduard Gracia, Estefania Moreno, Josefa Mallol, Carme Lluís, Enric I. Canela, Vicent Casadó, Moonlighting Adenosine Deaminase: A Target Protein for Drug Development, Medicinal Research Reviews, 2015, 35, 1
  3. 3
    Yinxia Chao, Siew Cheng Wong, Eng King Tan, Evidence of Inflammatory System Involvement in Parkinson’s Disease, BioMed Research International, 2014, 2014, 1

    CrossRef

  4. You have free access to this content4
    T. Hattori, S. Orimo, M. Hallett, T. Wu, A. Inaba, R. Azuma, H. Mizusawa, Relationship and factor structure in multisystem neurodegeneration in Parkinson's disease, Acta Neurologica Scandinavica, 2014, 130, 6
  5. 5
    Izaskun Villar-Menéndez, Fabiana Nuñez, Sara Díaz-Sánchez, José Luis Albasanz, Jaume Taura, Víctor Fernández-Dueñas, Isidre Ferrer, Mairena Martín, Francisco Ciruela, Marta Barrachina, Striatal adenosine A2A receptor expression is controlled by S-adenosyl-L-methionine-mediated methylation, Purinergic Signalling, 2014, 10, 3, 523

    CrossRef